Please use this identifier to cite or link to this item:
https://ninho.inca.gov.br/jspui/handle/123456789/6276| Title: | INCA participa de estudo inédito sobre novo fármaco para câncer do colo do útero |
| Other Titles: | Informe INCA 417 |
| Authors: | Instituto Nacional de Câncer José Alencar Gomes da Silva Instituto Nacional de Câncer (Brasil) INCA |
| Keywords: | Neoplasias do Colo do Útero/terapia Uterine Cervical Neoplasms/therapy Neoplasias del Cuello Uterino/terapia Avaliação de Medicamentos Drug Evaluation Evaluación de Medicamentos Cemiplimabe Melo, Andréia Cristina de |
| Issue Date: | Mar-2022 |
| Publisher: | INCA |
| URI: | http://sr-vmlxaph03:8080/jspui/handle/123456789/6276 |
| Appears in Collections: | Informe INCA 417 |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Informe-INCA-2022-417-4-INCA-participa-de.pdf | 219.12 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.